STOCK TITAN

Zoetis (NYSE: ZTS) EVP receives new RSU and option awards

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Lagano Roxanne reported acquisition or exercise transactions in this Form 4 filing.

Zoetis Inc. Executive Vice President Roxanne Lagano reported equity awards on February 18, 2026. She received 3,664 restricted stock units and 14,499 stock options for Zoetis common stock, granted under the company’s equity and incentive plan.

Each RSU represents a right to one Zoetis share and is scheduled to vest in three equal installments on the first, second, and third anniversaries of the grant date, subject to continued service and certain earlier-vesting events. The stock options also vest in three equal annual installments and expire on the tenth anniversary of the grant date.

Positive

  • None.

Negative

  • None.
Insider Lagano Roxanne
Role Executive Vice President
Type Security Shares Price Value
Grant/Award Restricted Stock Unit 3,664 $0.00 --
Grant/Award Stock Option 14,499 $0.00 --
holding Restricted Stock Unit -- -- --
holding Restricted Stock Unit -- -- --
holding Stock Option -- -- --
holding Stock Option -- -- --
holding Stock Option -- -- --
holding Stock Option -- -- --
Holdings After Transaction: Restricted Stock Unit — 3,664 shares (Direct); Stock Option — 14,499 shares (Direct)
Footnotes (1)
  1. Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 18, 2026; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Not applicable. One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 19, 2025; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. One-third of each RSU vests and is settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 6, 2024; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan. One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 18, 2026. Each option expires on the tenth anniversary of the date of grant. One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 19, 2025. One-third of each option vests on the first, second and third anniversaries of the date of grant, February 6, 2024. One-third of each option vested on the first, second and third anniversaries of the date of grant, February 8, 2023. Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,377 options granted February 8, 2022 at an exercise price of $201.30 per option. Each option vested on the third anniversary of the date of grant.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lagano Roxanne

(Last) (First) (Middle)
C/O ZOETIS INC.
10 SYLVAN WAY

(Street)
PARSIPPANY NJ 07054

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Zoetis Inc. [ ZTS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Executive Vice President
3. Date of Earliest Transaction (Month/Day/Year)
02/18/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit(1) (2) 02/18/2026 A 3,664 (3) (4) Common Stock 3,664 $0 3,664 D
Restricted Stock Unit(1) (2) (5) (4) Common Stock 2,250.4257 2,250.4257 D
Restricted Stock Unit(1) (2) (6) (4) Common Stock 545 545 D
Stock Option(7) $129.13 02/18/2026 A 14,499 (8) (9) Common Stock 14,499 $0 14,499 D
Stock Option(7) $156.64 (10) (9) Common Stock 8,642 8,642 D
Stock Option(7) $196.14 (11) (9) Common Stock 6,127 6,127 D
Stock Option(7) $162.07 (12) (9) Common Stock 6,542 6,542 D
Stock Option(13) (14) (15) (9) Common Stock 20,221 20,221(14) D
Explanation of Responses:
1. Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").
2. Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.
3. One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 18, 2026; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
4. Not applicable.
5. One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 19, 2025; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
6. One-third of each RSU vests and is settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 6, 2024; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
7. Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.
8. One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 18, 2026.
9. Each option expires on the tenth anniversary of the date of grant.
10. One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 19, 2025.
11. One-third of each option vests on the first, second and third anniversaries of the date of grant, February 6, 2024.
12. One-third of each option vested on the first, second and third anniversaries of the date of grant, February 8, 2023.
13. Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.
14. 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,377 options granted February 8, 2022 at an exercise price of $201.30 per option.
15. Each option vested on the third anniversary of the date of grant.
Remarks:
/s/ Brenda Santuccio, as Attorney-in-Fact 02/19/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Zoetis (ZTS) executive Roxanne Lagano report in this Form 4 filing?

Roxanne Lagano reported receiving new equity awards from Zoetis. The filing shows grants of 3,664 restricted stock units and 14,499 stock options, all awarded under the Zoetis equity and incentive plan as part of her executive compensation package.

How many restricted stock units did Roxanne Lagano receive from Zoetis (ZTS)?

She received 3,664 restricted stock units from Zoetis. Each RSU represents a contingent right to receive one share of Zoetis common stock, subject to vesting conditions based on continued service and certain potential earlier-vesting corporate or employment events.

How many stock options were granted to Roxanne Lagano by Zoetis (ZTS)?

Zoetis granted 14,499 stock options to Roxanne Lagano. These options were issued under the company’s equity and incentive plan, providing the right to buy Zoetis common stock, with vesting over time and an expiration ten years from the grant date.

What is the vesting schedule for Roxanne Lagano’s new Zoetis (ZTS) RSUs?

The RSUs vest in three equal annual installments. One-third of each restricted stock unit award is scheduled to vest on the first, second, and third anniversaries of the February 18, 2026 grant date, contingent on her continued service and specific earlier-vesting conditions.

What is the vesting schedule for the Zoetis (ZTS) stock options granted to Roxanne Lagano?

The stock options vest in three equal tranches over three years. One-third of each option award becomes exercisable on the first, second, and third anniversaries of the February 18, 2026 grant date, with each option expiring on the tenth anniversary of its grant.

Do Roxanne Lagano’s Zoetis (ZTS) RSUs include dividend equivalent units?

Yes, the RSU position includes dividend equivalent units. The filing states the grant represents restricted stock units and dividend equivalent units automatically issued on those RSUs, all under the Zoetis Amended and Restated 2013 Equity and Incentive Plan.